0.1483
Precedente Chiudi:
$0.159
Aprire:
$0.15
Volume 24 ore:
687.25K
Relative Volume:
0.13
Capitalizzazione di mercato:
$2.24M
Reddito:
-
Utile/perdita netta:
$-8.74M
Rapporto P/E:
-0.0723
EPS:
-2.05
Flusso di cassa netto:
$-8.25M
1 W Prestazione:
-12.94%
1M Prestazione:
-50.42%
6M Prestazione:
-99.66%
1 anno Prestazione:
-99.82%
Glucotrack Inc Stock (GCTK) Company Profile
Nome
Glucotrack Inc
Settore
Industria
Telefono
972 (8) 675-7878
Indirizzo
301 RT 17 NORTH, RUTHERFORD
Confronta GCTK con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
GCTK
Glucotrack Inc
|
0.1488 | 2.24M | 0 | -8.74M | -8.25M | -2.05 |
![]()
ISRG
Intuitive Surgical Inc
|
466.95 | 175.60B | 8.35B | 2.32B | 1.30B | 6.41 |
![]()
BDX
Becton Dickinson Co
|
195.01 | 59.07B | 20.64B | 1.73B | 2.94B | 6.02 |
![]()
ALC
Alcon Inc
|
91.44 | 44.80B | 9.91B | 1.02B | 665.00M | 2.05 |
![]()
RMD
Resmed Inc
|
209.79 | 31.51B | 4.93B | 1.25B | 1.38B | 8.47 |
![]()
COO
The Cooper Companies, Inc.
|
78.25 | 15.83B | 3.90B | 392.30M | 288.10M | 1.95 |
Glucotrack Inc Borsa (GCTK) Ultime notizie
GlucoTrack Joins EU Bionic Pancreas Initiative - TipRanks
Glucotrack to Participate in FORGETDIABETES, a Prominent European Research Initiative to Develop a Bionic Pancreas - The Manila Times
Major Breakthrough: Glucotrack Selected for EU's Revolutionary Bionic Pancreas Project - Stock Titan
GCTK stock plunges to 52-week low of $0.15 amid market turmoil By Investing.com - Investing.com South Africa
GCTK stock plunges to 52-week low of $0.15 amid market turmoil - Investing.com India
Glucotrack faces Nasdaq delisting over share price rule - Investing.com Australia
Glucotrack faces Nasdaq delisting over share price rule By Investing.com - Investing.com South Africa
Glucotrack partners with OneTwo Analytics for AI diabetes data analysis By Investing.com - Investing.com South Africa
6 Alternatives to Apple’s Non-Invasive Glucose Monitoring You Can Try Now - The Mac Observer
GlucoTrack Partners with OneTwo Analytics for AI-Driven Insights - TipRanks
Glucotrack partners with OneTwo Analytics for AI diabetes data analysis - Investing.com Australia
Glucotrack and OneTwo Analytics to Collaborate for Clinical Study Analysis on Its Continuous Blood Glucose Monitor - GlobeNewswire
Game-Changing Implantable Glucose Monitor Partners With AI Firm for 3-Year Clinical Study - Stock Titan
Glucotrack Reports Transformative Year with Clinical Advances - TipRanks
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
GlucoTrack Advances with Clinical Trials and Funding Boost - TipRanks
Glucotrack, Inc. SEC 10-K Report - TradingView
Glucotrack Reports Full Year 2024 Financial Results and Recent Corporate Highlights - The Manila Times
Regencell, GlucoTrack, TC Biopharm, AbbVie, Actinium: 5 Health Care Stocks That Lit Up Retail Discussions Last Week - MSN
GCTK Stock Plummets to 52-Week Low of $0.20 Amid Market Turbulence By Investing.com - Investing.com South Africa
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
GCTK Stock Plummets to 52-Week Low of $0.20 Amid Market Turbulence - Investing.com India
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
GlucoTrack Inc (NASDAQ: GCTK) Analysts Prediction On How Much It Could Rise - Stocks Register
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Regencell, GlucoTrack, TC Biopharm, AbbVie, Actinium: 5 Health Care Stocks That Lit Up Retail Discussions Last - Asianet Newsable
Why Did GlucoTrack Plunge 15.72%? - AInvest
Why AZEK Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket - Benzinga
Glucotrack to Present at TechBio Showcase™ 2025 - The Globe and Mail
GCTK stock plunges to 52-week low, touches $0.31 By Investing.com - Investing.com Australia
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
GCTK stock plunges to 52-week low, touches $0.31 - Investing.com
Pre-market Movers: IBO, ALUR, GCTK, TELA... - RTTNews
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Why Ouster Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket - Benzinga
Glucotrack to present breakthrough blood glucose monitoring data at conference - ROI-NJ.com
Glucotrack To Present First-In-Human Results Of Continuous Blood Glucose Monitor At ATTD 2025 - Nasdaq
Implantable, Hidden Continuous Glucose Monitoring Could Revolutionize Diabetes Care - Nasdaq
GlucoTrack to Present Data on New Glucose Monitoring System - TipRanks
Glucotrack to Present First-In-Human Study Results for Continuous Blood Glucose Monitor at the 2025 International Conference on Advanced Technologies & Treatment for Diabetes - The Manila Times
Glucotrack, Inc. Announces First-in-Human Trial Data for Continuous Blood Glucose Monitoring System to be Presented at 2025 ATTD Conference - Nasdaq
Glucotrack Inc Azioni (GCTK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):